» Articles » PMID: 19506719

Brain Endothelial Cell-cell Junctions: How to "open" the Blood Brain Barrier

Overview
Date 2009 Jun 10
PMID 19506719
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is a highly specialized structural and biochemical barrier that regulates the entry of blood-borne molecules into brain, and preserves ionic homeostasis within the brain microenvironment. BBB properties are primarily determined by junctional complexes between the cerebral endothelial cells. These complexes are comprised of tight and adherens junctions. Such restrictive angioarchitecture at the BBB reduces paracellular diffusion, while minimal vesicle transport activity in brain endothelial cells limits transcellular transport. Under normal conditions, this largely prevents the extravasation of large and small solutes (unless specific transporters are present) and prevents migration of any type of blood-borne cell. However, this is changed in many pathological conditions. There, BBB disruption ("opening") can lead to increased paracellular permeability, allowing entry of leukocytes into brain tissue, but also contributing to edema formation. In parallel, there are changes in the endothelial pinocytotic vesicular system resulting in the uptake and transfer of fluid and macromolecules into brain parenchyma. This review highlights the route and possible factors involved in BBB disruption in a variety of neuropathological disorders (e.g. CNS inflammation, Alzheimer's disease, Parkinson's disease, epilepsy). It also summarizes proposed signal transduction pathways that may be involved in BBB "opening".

Citing Articles

Drug Delivery Across the Blood-Brain Barrier: A New Strategy for the Treatment of Neurological Diseases.

Jiao Y, Yang L, Wang R, Song G, Fu J, Wang J Pharmaceutics. 2025; 16(12.

PMID: 39771589 PMC: 11677317. DOI: 10.3390/pharmaceutics16121611.


Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain.

Latham A, Geer C, Ackart D, Weninger K, Gross C, Podell B PLoS One. 2024; 19(12):e0307577.

PMID: 39739680 PMC: 11687776. DOI: 10.1371/journal.pone.0307577.


Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.

Doifode T, Maziero M, Quevedo J, Barichello T Methods Mol Biol. 2024; 2868:73-90.

PMID: 39546226 DOI: 10.1007/978-1-0716-4200-9_5.


Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood-brain barrier.

Shamul J, Wang Z, Gong H, Ou W, White A, Moniz-Garcia D Nat Biomed Eng. 2024; .

PMID: 39304761 DOI: 10.1038/s41551-024-01250-2.


Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model.

Madani F, Morovvati H, Webster T, Najaf Asaadi S, Rezayat S, Hadjighassem M Sci Rep. 2024; 14(1):19516.

PMID: 39174603 PMC: 11341868. DOI: 10.1038/s41598-024-69888-1.


References
1.
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N . Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003; 161(3):653-60. PMC: 2172943. DOI: 10.1083/jcb.200302070. View

2.
Annunziata P, Cioni C, Santonini R, Paccagnini E . Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium. J Neuroimmunol. 2002; 131(1-2):41-9. DOI: 10.1016/s0165-5728(02)00262-x. View

3.
Betz A, Firth J, GOLDSTEIN G . Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res. 1980; 192(1):17-28. DOI: 10.1016/0006-8993(80)91004-5. View

4.
Vogel C, Bauer A, Wiesnet M, Preissner K, Schaper W, Marti H . Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol. 2007; 212(1):236-43. DOI: 10.1002/jcp.21022. View

5.
Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, Tsukita S . Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol. 2001; 154(3):491-7. PMC: 2196413. DOI: 10.1083/jcb.200103047. View